Pharma-Bio Serv (PBSV) Profit After Tax (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Profit After Tax of $232986.0 for Q2 2026, up 144.34% year-over-year from $95353.0 in Q2 2025, and up 346.45% on a QoQ basis from -$94535.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Profit After Tax (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Profit After Tax history runs 17 years deep, the most recent figure standing at $232986.0 for Q2 2026.
- Profit After Tax for Q2 2026 came in at $232986.0, up 144.34% year-over-year; the trailing twelve-month figure through Apr 2026 was -$175528.0 (up 77.26% YoY), and the FY2025 annual result was -$100463.0, up 92.2% from the prior year.
- Profit After Tax came in at $232986.0 for Q2 2026 at Pharma-Bio Serv, up from -$94535.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $526242.0 in Q3 2023 to a low of -$493857.0 in Q4 2024.
- A 5-year average of $52729.8 and a median of $51944.5 in 2025 frame the typical range for Profit After Tax.
- The largest YoY upside for Profit After Tax was 144.34% in 2026 against a maximum downside of 1207.49% in 2026.
- Over 5 years, Profit After Tax stood at $341640.0 in 2022, then plunged by 115.15% to -$51765.0 in 2023, then tumbled by 854.04% to -$493857.0 in 2024, then jumped by 99.98% to -$102.0 in 2025, then soared by 228517.65% to $232986.0 in 2026.
- The last three Profit After Tax figures came in at $232986.0 (Q2 2026), -$94535.0 (Q1 2026), and -$102.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 148.77 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 35.13 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -13.47 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 19.11 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 43.28 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 3.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 11.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 232,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 232,986.00 |
| Jan 31, 2026 | -94,535.00 |
| Oct 31, 2025 | -102.00 |
| Jul 31, 2025 | -313,877.00 |
| Apr 30, 2025 | 95,353.00 |
| Jan 31, 2025 | 8,536.00 |
| Oct 31, 2024 | -493,857.00 |
| Jul 31, 2024 | -381,782.00 |
| Apr 30, 2024 | -313,375.00 |
| Jan 31, 2024 | -270,719.00 |
| Oct 31, 2023 | -51,765.00 |
| Jul 31, 2023 | 526,242.00 |
| Apr 30, 2023 | 404,654.00 |
| Jan 31, 2023 | 426,432.00 |
| Oct 31, 2022 | 341,640.00 |
| Jul 31, 2022 | 288,034.00 |
| Apr 30, 2022 | 240,027.00 |
| Jan 31, 2022 | 305,244.00 |
| Oct 31, 2021 | -4.87 Mn |
| Jul 31, 2021 | 2.28 Mn |